- Home
- MOLN vs FSP Comparison
MOLN vs FSP Comparison
Compare MOLN & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- FSP
- Stock Information
- Founded
- MOLN 2004
- FSP 1981
- Country
- MOLN Switzerland
- FSP United States
- Employees
- MOLN N/A
- FSP N/A
- Industry
- MOLN
- FSP Real Estate Investment Trusts
- Sector
- MOLN
- FSP Real Estate
- Exchange
- MOLN Nasdaq
- FSP Nasdaq
- Market Cap
- MOLN 195.4M
- FSP 187.5M
- IPO Year
- MOLN 2021
- FSP N/A
- Fundamental
- Price
- MOLN $5.56
- FSP $1.86
- Analyst Decision
- MOLN
- FSP
- Analyst Count
- MOLN 0
- FSP 0
- Target Price
- MOLN N/A
- FSP N/A
- AVG Volume (30 Days)
- MOLN 7.1K
- FSP 310.2K
- Earning Date
- MOLN 03-13-2025
- FSP 02-24-2025
- Dividend Yield
- MOLN N/A
- FSP 2.15%
- EPS Growth
- MOLN N/A
- FSP N/A
- EPS
- MOLN N/A
- FSP N/A
- Revenue
- MOLN $7,105,397.00
- FSP $126,508,000.00
- Revenue This Year
- MOLN N/A
- FSP N/A
- Revenue Next Year
- MOLN $29.41
- FSP $0.02
- P/E Ratio
- MOLN N/A
- FSP N/A
- Revenue Growth
- MOLN N/A
- FSP N/A
- 52 Week Low
- MOLN $3.32
- FSP $1.47
- 52 Week High
- MOLN $12.70
- FSP $2.58
- Technical
- Relative Strength Index (RSI)
- MOLN 53.39
- FSP 51.16
- Support Level
- MOLN $4.98
- FSP $1.69
- Resistance Level
- MOLN $5.91
- FSP $1.90
- Average True Range (ATR)
- MOLN 0.27
- FSP 0.06
- MACD
- MOLN 0.08
- FSP 0.00
- Stochastic Oscillator
- MOLN 69.45
- FSP 77.27
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.